Fig. 2From: Economic assessment of incorporating the hexavalent vaccine as part of the National Immunization Program of PeruOne way sensitive analysis. Variation in estimated total annual costs for the payer (USD, $) when modifying the hexavalent vaccine acquisition cost per dose. USD, $1 equal to S/ 3.374 Peruvian Soles (average accounting exchange rate reported on December 31, 2018 by the Peruvian Superintendence of Banks, Insurance and Private Pension Fund Administrators [Superintendencia de Banca, Seguros y AFP]).[36]. USD, US dollarBack to article page